Koyfin Home > Directory > Health Care > Adverum Biotechnlgs > Altman Z-score

Adverum Biotechnlgs Altman Z-score Chart (ADVM)

Adverum Biotechnlgs annual/quarterly Altman Z-score from 2013 to 2019.
  • Adverum Biotechnlgs Altman Z-score for the quarter ending December 12, 2019 was 4.40 a -320.67% decrease of -14.12 year over year
  • Adverum Biotechnlgs Altman Z-score for the last 12 months ending June 06, 2020 was 9.10 a 57.78% increase of 5.26 year over year
  • Adverum Biotechnlgs Annual Altman Z-score for 2019 was 3.95 a -254.78% decrease of -10.07 from 2018
  • Adverum Biotechnlgs Annual Altman Z-score for 2018 was 14.02 a 81.49% increase of 11.42 from 2017
  • Adverum Biotechnlgs Annual Altman Z-score for 2017 was 2.59 a -50.32% decrease of -1.31 from 2016
Other Balance Sheet Metrics:
  • Adverum Biotechnlgs Total Assets for the quarter ending September 09, 2018 was $226m a 10.62% increase of 24m year over year
  • Adverum Biotechnlgs Other Liabilities for the quarter ending December 12, 2018 was $2m a -14.42% decrease of 0m year over year
  • Adverum Biotechnlgs Total Equity for the quarter ending September 09, 2018 was $216m a 14.63% increase of 32m year over year
View Chart On Koyfin

Quarterly ADVM Altman Z-score Data

12/20194.40
09/20197.78
12/201810.40
09/201818.52
06/201815.53
03/201817.34
12/20173.27
09/20172.61
06/20173.10
03/20172.29

Annual ADVM Altman Z-score Data

20193.95
201814.02
20172.59
20163.90
201531.29
201438.22
2013-19.45
2012-29.90